USPTO Granted Patents = 5 (Patent Applications = 1)
CIPO Patents = 1
EPO Patents = 2 (Patent Applications = 1)
Average Co-Inventor Count = 12.4
ph-index = 4
Forward Citations = 63(Granted Patents)
Location History:
- Walingford, CT (US) (2011)
- Plainsboro, NJ (US) (2011)
- Wallingford, CT (US) (2006 - 2020)
Company Filing History:
Schering Corporation
Pharmacopeia Drug Discovery, Inc.
Rgenix, Inc.
4. 1 out of 305
Neurogen Corporation
where one patent can have more than one assignee
Years Active: 2006-2020
Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
2. 7964646 - 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands (2011-06-21),
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
1 patent pending:
Please report any incorrect information to support@idiyas.com
1 patent (CIPO):
Please report any incorrect information to support@idiyas.com
Please report any incorrect information to support@idiyas.com
2 patents (EPO):
Please report any incorrect information to support@idiyas.com
1 patent pending (EPO):
Please report any incorrect information to support@idiyas.com